Thomas Klopstock, Prof. Dr. - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05522374Recruiting

TIRCON International NBIA Registry

AceruloplasminemiaBeta-Propeller Protein-Associated Neurodegeneration (BPAN)COASY Protein-associated Neurodegeneration (CoPAN)+8 more

PrincipalinvestigatorStart date: 2012-06-14

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Aceruloplasminemia1 Beta-Propeller Protein-Associated Neurodegeneration (BPAN)1 COASY Protein-associated Neurodegeneration (CoPAN)1 Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN)1 Kufor Rakeb Syndrome1 Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN)1 Neurodegeneration With Brain Iron Accumulation (NBIA)1 Neuroferritinopathy1

Affiliations

LMU Klinikum, Friedrich-Baur-Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Susan J Hayflick, MD

Oregon Health and Science University

Shared therapeutic areas:

Pantothenate Kinase-Associated NeurodegenerationNeurodegeneration With Brain Iron Accumulation (NBIA)

Similarity Score5%

Vincent MICHAUD

University Hospital, Bordeaux

Shared therapeutic areas:

Neurodegeneration With Brain Iron Accumulation (NBIA)

Similarity Score3%

Elliott Vichinsky, MD

Children's Hospital & Research Center at Oakland Hematology/ Oncology, Pediatric Rehabilitation

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Penelope Hogarth, M.D.

Oregon Health and Science University

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Patrick Chinnery, MD

Newcastle University Institute of Human Genetics

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Thomas Klopstock, MD

LMU Klinikum

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Patricia FERGELOT MAURIN

University Hospital, Bordeaux

Shared therapeutic areas:

Neurodegeneration With Brain Iron Accumulation (NBIA)

Similarity Score3%

Fernando Tricta, MD

ApoPharma Inc.

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Thomas Klopstock, MD

Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Elliott Vichinsky, MD

UCSF Benioff Children's Hospital Oakland

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05522374PrincipalInvestigator

TIRCON International NBIA Registry

AceruloplasminemiaBeta-Propeller Protein-Associated Neurodegeneration (BPAN)COASY Protein-associated Neurodegeneration (CoPAN)+8 more

Recruiting

All 1 trials loaded